Agrylin (anagrelide hydrochloride) Capsules(not a new route of administration), Roberts , NDA 20-333/SE1-002 ANAGRELIDE HYDROCHLORIDE Capsule; 0.5MG BASE AGRYLIN SHIRE 020333 ANAGRELIDE HYDROCHLORIDE Capsule; 1MG BASE AGRYLIN SHIRE | Agrylin (anagrelide hydrochloride) Capsules, Shire Pharma, Patient Population Altered & Labeling Revision | Agrylin (anagrelide hydrochloride) Capsules, Shire Pharma, Labeling Revision | Anagrelide Hydrochloride Capsules, Watson, Approval | Anagrelide Hydrochloride Capsules, Ivax, Approval | Anagrelide Hydrochloride Capsules, Roxane, Approval | Anagrelide Hydrochloride Capsules, Barr, Approval | Anagrelide Hydrochloride Capsules, Eon, Approval | Anagrelide Hydrochloride Capsules, Mylan, Approval | Anagrelide Hydrochloride Capsules, Impax, Approval | Anagrelide Hydrochloride Capsules, Ivax, Approval

For the most up-to-date approval information, please locate this API using the drug index.